Delgocitinib Uses, Dosage, Side Effects and more

Delgocitinib is under investigation in clinical trial NCT03683719 (Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 Mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema).

Trade Name Delgocitinib
Generic Delgocitinib
Delgocitinib Other Names Delgocitinib
Type
Formula C16H18N6O
Weight Average: 310.361
Monoisotopic: 310.154209224
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share